Growth Hormone & Igf Research

Papers
(The median citation count of Growth Hormone & Igf Research is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Editorial Board15
Editorial Board15
David B. Dunger: in memoriam 1948–202115
Pregnancy-associated plasma protein-A (PAPP-A) and cardiovascular disease12
Editorial Board12
Editorial Board10
Evaluation of growth hormone deficiency in women with unexplained infertility10
Efficacy and safety of growth hormone therapy in children with Noonan syndrome9
Exercise combined with lysine-inositol vitamin B12 promotes height growth in children with idiopathic short stature9
Prevalence of refractoriness when testing growth hormone levels in children9
The effect of milk and rapeseed protein on growth factors in 7–8 year-old healthy children – A randomized controlled trial8
Economic and clinical burden of comorbidities among patients with acromegaly8
IGF-1 knockdown inhibits phosphorylation of Akt and ERK in chicken embryonic myotubes7
Prevalence and predictors of abnormal glucose tolerance and its resolution in acromegaly: Single Centre retrospective study of 90 cases7
Editorial Board7
Serum IGF-I concentrations are low in female bodybuilders in the pre-contest phase6
Editorial Board6
Response to growth hormone therapy in ring chromosome 15: Review and evidence from a new case on possible beneficial effect in neurodevelopment6
Biomarkers of growth and carbohydrate metabolism in neonatal rats supplemented with fish oil and/or antioxidants during intermittent hypoxia6
Meta-analysis of MspI derived variants of growth hormone gene associated with milk yield in dairy cattle6
Changes in anterior segment parameters and presence of dry eye disease in patients with acromegaly: A Sirius topography study combined with meibography5
Effect of a copper intrauterine device on HLA-G and IGF-II levels during pregnancy5
The necessity of magnetic resonance imaging in the evaluation of pediatric growth hormone deficiency: Lessons from a large academic center5
Comparison of growth response and adverse reaction according to growth hormone dosing strategy for children with short stature: LG Growth Study5
Effect of metformin on thyroid cancer risk in patients with acromegaly: A preliminary observational study5
Editorial Board5
Editorial Board5
Impact of disease activity on cognitive and psychological outcomes in acromegaly: A prospective study4
Adult height and long-term outcomes after rhIGF-1 therapy in two patients with PAPP-A2 deficiency4
Association of rs35767 polymorphism in the IGF1 gene with athletic performance in power and endurance sports: A meta-analysis4
The prevalence of IGF-I axis genetic polymorphisms among decathlon athletes4
The effect of methylphenidate on the dopamine and growth hormone response to exercise in children with attention-deficit hyperactivity disorder4
Do neurosteroids have impact on depression and cognitive functions in cases with acromegaly?4
Administration of insulin like growth factor I (IGF I) lowers serum lipoprotein(a)-impact on atherosclerotic cardiovascular disease4
Regulation of 11β-HSD1 by GH/IGF-1 in key metabolic tissues may contribute to metabolic disease in GH deficient patients4
Reduced exercise-induced growth hormone secretion among children with attention-deficit hyperactivity disorder4
Comparison of two prediction models in a clinical setting to predict growth in prepubertal children on recombinant growth hormone4
Corrigendum to “Insulin-like growth Factors I and II receptors in the breast cancer disparity” among African-American women [Growth Hormone & IGF Research 20 (2010) 245–254]3
Editorial Board3
Adult patients with Laron syndrome tend to develop the metabolic syndrome3
Acromegaly in humans and cats: Pathophysiological, clinical and management resemblances and differences3
Prostate-specific antigen (PSA) levels in men with Prader-Willi syndrome3
The regulation of proliferation and apoptosis in hepatocellular carcinoma via insulin-like growth factor 1 receptor3
Editorial Board3
The coexistence of newly diagnosed acromegaly with primary empty sella: More frequent than expected?3
Illness-related burden, personal resources and need for support in patients with acromegaly: Results of a focus group analysis3
Dental arches in inherited severe isolated growth hormone deficiency3
Duration-specific association between plasma IGFBP7 levels and diabetic complications in patients with type 2 diabetes mellitus3
Effects of raloxifene administration on serum levels of insulin-like growth factor-1 and insulin-like growth factor-binding protein 3 levels: A systematic review and meta-analysis of randomized contro3
Pharmacokinetics and pharmacodynamics of once-weekly administration of JR-142, a long-acting albumin-fused human growth hormone: A rondemized, placebo-controlled phase 1 study3
Growth hormone secreting pituitary carcinomas: Case report and review of literature3
Growth hormone modulates Trypanosoma cruzi infection in vitro3
Editorial Board2
RNA-seq and nuclear proteomics provide insights into the lactation regulation mechanism of goat transfected IGF-I and GH recombinant vectors2
Pharmacodynamics, pharmacokinetics, and toxicology of Fc-growth hormone fusion protein in macaques2
Pediatric growth hormone deficiency: Understanding the patient and caregiver perspectives2
Novel gross deletion at the LHX4 gene locus in a child with growth hormone deficiency2
Editorial Board2
Liver and muscle-specific effects of phoenixin-20 on the insulin-like growth factor system mRNAs in zebrafish2
Growth hormone responses during arginine and clonidine stimulation test: Correlations with patients' auxological and metabolic parameters in a single centre study2
A combined top-down and bottom-up LC-HRMS/MS method for the quantification of human growth hormone in plasma and serum2
Identification and differentiation of somapacitan, a long-acting growth hormone derivative, and recombinant human growth hormone in equine plasma by LC-HRMS for doping control purpose2
0.058847188949585